Suzhou Ronnsi Pharma

Suzhou Ronnsi Pharma is a clinical-stage biopharmaceutical company based in Suzhou, China, specializing in the development of complex injectable formulations and advanced drug delivery systems. The company leverages proprietary technology platforms in liposomes, microspheres, and nanocrystals to create high-value therapeutics with improved pharmacokinetic profiles and reduced toxicity. Their robust pipeline focuses on critical therapeutic areas such as oncology, analgesia, and anti-infectives, featuring advanced candidates like liposomal irinotecan and bupivacaine. By integrating R&D with high-standard GMP manufacturing capabilities, Ronnsi Pharma aims to address unmet medical needs through the optimization of established drug molecules. The company is strategically positioned to serve both the domestic Chinese market and international regulatory pathways.